http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008195647-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a177f0fa84b1b2134e13caa36974ce3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
filingDate 2007-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5452c6cb40ba38ee969984af011df93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14b159f406e15e5cc5a3f5d97e7eac81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93d2a8da6b58a69fa2cbeb9502f0c586
publicationDate 2008-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008195647-A
titleOfInvention Process for producing optically active α-hydroxysilanes and novel optically active α-hydroxysilane compounds
abstract An object of the present invention is to provide a method for producing optically active α-hydroxysilanes which can reduce the amount of a catalyst and generate less by-products, and a novel optically active α-hydroxysilane compound. A Ru complex is used as a catalyst and is represented by the general formula (II). [Chemical 2] (In the formula II, R 12 to R 14 may be the same or different, and each may have a functional group, an aromatic group, a heterocyclic ring, a chain or cyclic alkyl group, an alkenyl group, or an alkynyl group. Two of R 12 to R 14 may be bonded to form a ring; R 15 represents an aromatic group, a heterocyclic ring, a chain or cyclic alkyl group, an alkenyl group, or an alkynyl group; ) To produce optically active α-hydroxysilanes. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010114151-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010254684-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011051929-A
priorityDate 2007-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009544621-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455667478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456500829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426253908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4189906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18994618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455668095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426021660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419705849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22831428

Total number of triples: 45.